Stalicla Company
STALICLA is a Swiss biotechnology company developing precision medicine treatments for patients with Neurodevelopmental disorders
Technology:
Pharmaceuticals
Industry:
Clinical development, NeuroTech
Headquarters:
Genève, Geneve, Switzerland
Founded Date:
2017-05-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
1
Total Funding:
33460000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-12-01
Last Funding Type:
Convertible Note
Register and Claim Ownership